Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

TRAPP is a multisubunit complex that functions in membrane traffic. Mutations in the mammalian TRAPP protein C2 are linked to the skeletal disorder spondyloepiphyseal dysplasia tarda (SEDT) that is thought to arise from an inability to secrete procollagen from the endoplasmic reticulum. Here, we show that C2 binds to the SNARE protein Syntaxin 5 and this interaction is weakened by an SEDT-causing missense mutation (D47Y). Interestingly, the equivalent mutation (D46Y) in the yeast C2 homolog Trs20p does not block anterograde traffic but did affect endocytosis. The trs20D46Y mutation interfered with the interaction between Trs20p and Trs85p (TRAPP III-specific subunit), Trs120p and Trs130p (TRAPP II-specific subunits). Size exclusion chromatography suggested that this yeast mutation destabilized the TRAPP III complex that is involved in autophagy. We further show that this mutation blocks both the selective cytosol-to-vacuole (cvt) pathway as well as non-selective autophagy. We demonstrate that the apparent molecular size of the TRAPP III complex is dependent upon membranes, and that the presence of TRAPP III is dependent upon Atg9p. Finally, we demonstrate that lipidated Bet3p is enriched in TRAPP III and that lipidation increases the efficiency of autophagy. Our study suggests that Trs20p acts as an adaptor for Trs85p and Trs120p and reveals complexities in TRAPP III assembly and function. The implications of C2D47Y in SEDT are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1111/tra.12095DOI Listing

Publication Analysis

Top Keywords

trapp iii
24
trapp
10
mutation blocks
8
blocks selective
8
non-selective autophagy
8
iii complex
8
mutation
6
iii
6
trs20 mutation
4
mutation mimics
4

Similar Publications

Mucopolysaccharidosis IIIA (MPS IIIA) is an autosomal recessive lysosomal disease caused by the deficiency of N-sulfoglucosamine sulfohydrolase (SGSH), due to biallelic mutations in the SGSH gene. We conducted a retrospective study utilizing data from MPS IIIA patients born from 1983 to 2024 diagnosed by the MPS Brazil Network. Sixty-eight patients with MPS IIIA were included.

View Article and Find Full Text PDF

A geminal antimony(iii)/phosphorus(iii) frustrated Lewis pair.

Chem Sci

July 2024

Chair of Inorganic and Structural Chemistry, Center for Molecular Materials CM2, Faculty of Chemistry, Bielefeld University, Universitätsstraße 25 Bielefeld 33615 Germany

The geminal Lewis pair (FC)SbCHP(Bu) (1) was prepared by reacting (FC)SbCl with LiCHP(Bu). Despite its extremely electronegative pentafluoroethyl substituents, the neutral 1 exhibits a relatively soft acidic antimony function according to the HSAB concept (hard-soft acid-base). These properties lead to a reversibility in the binding of CS to 1, as observed by VT-NMR spectroscopy, while no reaction with CO is observed.

View Article and Find Full Text PDF

Background: Transport protein particle (TRAPP) is a multiprotein complex that functions in localising proteins to the Golgi compartment. The TRAPPC11 subunit has been implicated in diseases affecting muscle, brain, eye and to some extent liver. We present three patients who are compound heterozygotes for a missense variant and a structural variant in the gene.

View Article and Find Full Text PDF

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.

N Engl J Med

June 2024

From the Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham (S.P.B.); LungenClinic Grosshansdorf (member of the German Center for Lung Research [DZL]), Airway Research Center North (ARCN), Grosshansdorf (K.F.R.), Christian-Albrechts University

Background: Dupilumab, a fully human monoclonal antibody that blocks the shared receptor component for interleukin-4 and interleukin-13, key and central drivers of type 2 inflammation, has shown efficacy and safety in a phase 3 trial involving patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation and an elevated risk of exacerbation. Whether the findings would be confirmed in a second phase 3 trial was unclear.

Methods: In a phase 3, double-blind, randomized trial, we assigned patients with COPD who had a blood eosinophil count of 300 cells per microliter or higher to receive subcutaneous dupilumab (300 mg) or placebo every 2 weeks.

View Article and Find Full Text PDF

Ancient DNA research in the past decade has revealed that European population structure changed dramatically in the prehistoric period (14,000-3000 years before present, YBP), reflecting the widespread introduction of Neolithic farmer and Bronze Age Steppe ancestries. However, little is known about how population structure changed from the historical period onward (3000 YBP - present). To address this, we collected whole genomes from 204 individuals from Europe and the Mediterranean, many of which are the first historical period genomes from their region (e.

View Article and Find Full Text PDF